Investment
Features
FeesSafety
Academy
More
Pluang+

Compare EPR Properties (EPR) vs NeoGenomics Inc. Common Stock (NEO) Price & Performance

EPR PropertiesTrade
NeoGenomics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

EPR Properties vs NeoGenomics Inc. Common Stock — how do they compare? EPR Properties trades at $54.64 (market cap $4.20B), while NeoGenomics Inc. Common Stock trades at $17.17 (market cap $2.14B). The key difference: EPR Properties is the larger of the two by market cap, and EPR Properties pays a 6.79% dividend while NeoGenomics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold EPR Properties for 48 Days and NeoGenomics Inc. Common Stock for 0 Days on average.

EPRNEO
Market Cap
$4.20B$2.14B
Volume
1,395,0442,228,400
Sector
Real EstateHealth
52-Week High
$64.32$19.91
52-Week Low
$48.71$7.19
Typical Hold Time
48 Days0 Days
Enterprise Value
$7.71B$2.44B
Dividend Yield
6.79%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

EPR Properties

EPR Properties (EPR) trades at $54.80, down 1.1% on the day, with a bearish technical signal from moving averages and a neutral stance from oscillators. The REIT shows strong profitability with a 91.41% gross margin and 37.66% net income margin, though net income dipped slightly in 2026. Recent news highlights its 6.5% dividend yield and focus on diversification beyond theaters into experiential properties, with Q3 2026 earnings due October 29, 2026.

The outlook is mixed: analyst consensus is a Buy with a $65.50 price target, implying ~20% upside, supported by a high yield and undervalued P/FFO. Risks include exposure to leisure and entertainment tenants, rising interest rates impacting financing costs, and the Q1 2026 earnings miss. Cash flow trends show a net outflow in 2026, warranting monitoring of dividend coverage.

NeoGenomics Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

EPR

No sentiment data available yet.

NEO
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About EPR Properties

EPR Properties is a REIT specializing in experiential real estate, including movie theaters and leisure destinations like ski resorts and water parks across the US and Canada.

Read more on EPR →

About NeoGenomics Inc. Common Stock

NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.

Read more on NEO →